CN Patent

CN109640988A — Cxcr4抑制剂及其用途

Assigned to X4 Pharmaceuticals Inc · Expires 2019-04-16 · 7y expired

What this patent protects

本发明提供了化合物、其组合物以及使用所述化合物和所述组合物的方法。

USPTO Abstract

本发明提供了化合物、其组合物以及使用所述化合物和所述组合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN109640988A
Jurisdiction: CN
Classification: —
Expires: 2019-04-16
Drug substance claim: No
Drug product claim: No
Assignee: X4 Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.